• Key Regulatory Agencies in Pharma M&A

  • Feb 20 2025
  • Length: 1 min
  • Podcast

Key Regulatory Agencies in Pharma M&A

  • Summary

  • When conducting an M&A transaction in the pharmaceutical or medical device industry, compliance must be a top priority. Regulatory agencies like the DOJ, FDA, OIG, and OCR have strengthened oversight, emphasizing successor liability and the need for strong compliance programs. Beyond FDA regulations, companies must consider fraud prevention, HIPAA, and evolving privacy laws at both federal and state levels. Ignoring these factors can lead to serious legal and financial consequences. Stay informed—compliance isn’t optional.


    Support the show

    Show more Show less

What listeners say about Key Regulatory Agencies in Pharma M&A

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.